SOFIA, MATTEO
 Distribuzione geografica
Continente #
AS - Asia 3.792
NA - Nord America 2.491
EU - Europa 2.486
SA - Sud America 570
AF - Africa 73
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 9.421
Nazione #
US - Stati Uniti d'America 2.363
SG - Singapore 2.179
RU - Federazione Russa 1.459
CN - Cina 872
BR - Brasile 484
HK - Hong Kong 341
IT - Italia 324
VN - Vietnam 186
FI - Finlandia 146
DE - Germania 131
UA - Ucraina 75
IE - Irlanda 74
GB - Regno Unito 69
CA - Canada 66
NL - Olanda 63
KR - Corea 43
SE - Svezia 38
MX - Messico 37
BD - Bangladesh 29
AR - Argentina 28
ZA - Sudafrica 26
EC - Ecuador 20
IN - India 20
JP - Giappone 20
PL - Polonia 20
FR - Francia 19
ID - Indonesia 19
TR - Turchia 17
CO - Colombia 12
CZ - Repubblica Ceca 11
IQ - Iraq 11
ES - Italia 10
PY - Paraguay 9
AT - Austria 7
SA - Arabia Saudita 7
CH - Svizzera 6
CI - Costa d'Avorio 6
UZ - Uzbekistan 6
VE - Venezuela 6
LT - Lituania 5
PE - Perù 5
DO - Repubblica Dominicana 4
EG - Egitto 4
HU - Ungheria 4
JO - Giordania 4
MA - Marocco 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BE - Belgio 3
CL - Cile 3
DZ - Algeria 3
GT - Guatemala 3
HN - Honduras 3
IL - Israele 3
KE - Kenya 3
KH - Cambogia 3
KZ - Kazakistan 3
LB - Libano 3
PK - Pakistan 3
TN - Tunisia 3
AL - Albania 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
BZ - Belize 2
CR - Costa Rica 2
DJ - Gibuti 2
HR - Croazia 2
IR - Iran 2
KG - Kirghizistan 2
MU - Mauritius 2
NE - Niger 2
NI - Nicaragua 2
NP - Nepal 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
RE - Reunion 2
RS - Serbia 2
RW - Ruanda 2
SN - Senegal 2
TJ - Tagikistan 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
AQ - Antartide 1
BB - Barbados 1
BG - Bulgaria 1
BJ - Benin 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CD - Congo 1
CG - Congo 1
CM - Camerun 1
CY - Cipro 1
EU - Europa 1
Totale 9.395
Città #
Singapore 1.022
Moscow 390
Hong Kong 341
Santa Clara 261
Hefei 232
Beijing 211
Ashburn 160
Chandler 157
Boston 113
Princeton 112
Los Angeles 97
Naples 93
Nanjing 89
Jacksonville 80
Millbury 76
Ho Chi Minh City 70
Munich 52
Hanoi 51
Buffalo 50
Dallas 50
Amsterdam 49
Wilmington 46
Redondo Beach 45
Seoul 43
São Paulo 43
Nanchang 41
New York 39
Seattle 35
Boardman 34
The Dalles 30
Ottawa 29
Norwalk 27
Dublin 25
Hebei 23
Jiaxing 23
Napoli 21
Shenyang 21
Turku 21
Stockholm 20
Montreal 19
Mexico City 18
Warsaw 18
Brooklyn 17
Falls Church 17
Tokyo 17
Poplar 14
Denver 13
Orem 13
Rio de Janeiro 13
Ankara 12
Chicago 12
Haiphong 12
Helsinki 12
Tianjin 12
Brasília 11
Belo Horizonte 8
Biên Hòa 8
Curitiba 8
Manchester 8
San Francisco 8
Atlanta 7
Brno 7
Caserta 7
Caxias do Sul 7
Changsha 7
Da Nang 7
Guayaquil 7
Houston 7
London 7
Phoenix 7
Recife 7
Shanghai 7
Toronto 7
Buenos Aires 6
Charlotte 6
Chennai 6
Dhaka 6
Frankfurt am Main 6
Goiânia 6
Kunming 6
Milan 6
Porto Alegre 6
Querétaro 6
Quito 6
Rome 6
Salvador 6
Tashkent 6
Anápolis 5
Asunción 5
Canoas 5
Duque de Caxias 5
Guarulhos 5
Johannesburg 5
Mountain View 5
Redmond 5
Settimo Torinese 5
Amman 4
Baghdad 4
Bern 4
Changchun 4
Totale 4.828
Nome #
Characterization of platelet-activating factor acetylhydrolase in human bronchoalveolar lavage. 107
Assessment of nasal and sinus nitric oxide output using single-breath humming exhalations. 106
Changes of lung volumes and respiratory muscle strength in patients with growth hormone deficiency 105
Fluoxetine ameliorates mucopolysaccharidosis type IIIA 102
Diagnosi precoce e corretto inquadramento clinico del paziente con disturbi respiratori 101
Acute exacerbation of idiopathic pulmonary fibrosis is associated to increase of pulmonary artery systolic pressure (PAPS). 101
Orthodeoxia without platypnea from interatrial defect associated with persistent left superior vena cava in the absence of pulmonary hypertension. 100
Endothelin in acute exacerbations of COPD. 98
CD8+ T-cell alveolitis in familial pulmonary alveolar microlithiasis 96
Endothelin abnormalities in patients with pulmonary embolism. 93
Impairment of lung volumes and respiratory muscle strength in adult patients with growth hormone deficiency 92
Effect of nitric oxide inhibition on immediate response to nasal allergen challenge in allergic rhinitis. 92
I livelli nasali di ossido nitrico in pazienti con rinite allergica stagionale in fase asintomatica e dopo esposizione all’allergene. 91
Azelastine in allergic bronchial asthma. 90
Humoral immune response IgG and IgA mediated against A60 in patients with pulmonary tuberculosis. 90
Abnormalities of renal endothelin during acute exacerbation in chronic obstructive pulmonary disease. 89
Aspetti clinico-epidemiologici delle infezioni acute delle vie respiratorie ad eziologia batterica (Rilievi in 176 casi). 88
Alterations of endothelin metabolism in patients with COPD and in patients with ARDS. 88
Attuali possibilità di studio morfo-funzionale del territorio bronchiolo-alveolare mediante tecniche di scintigrafia d'inalazione. 87
Effetti clinico-funzionali respiratori e modificazioni della reattività cutanea all'istamina ed all'allergene specifico durante trattamento con azelastina in broncoasmatici. Studio in doppio cieco verso placebo. 87
Risposta anticorpale IgG e IgA-mediata verso l’antigene micobatterico A60 in pazienti con tubercolosi polmonare. 87
Inhaled ultrasonically nebulized distilled water decreases exhaled nitric oxide in asthma. 86
Permeabilità bronchiale transepiteliale. Basi funzionali ed implicazioni cliniche. 86
Familial outbreak of multi-drug resistant tuberculosis (MDRT). 86
Difference between changes of bronchial mucosal permeability during endobronchial or inhaled allergenic challenge. 86
Endothelin-1 induces proliferation of human lung fibroblasts and IL-11 secretion through an ET(A) receptor-dependent activation of MAP kinases 84
Lung volumes and respiratory muscle strength in adult patients with childhood- or adult-onset growth hormone deficiency: effect of 12 months' growth hormone replacement therapy. 84
Chronic bronchitis: a double-blind clinical trial for the evaluation of the therapeutical effectiveness of orally administered Thymomodulin in the prevention of acute attacks. [Studio in doppio cieco sull'efficacia della Timomodulina per via orale nella prevenzione delle riacutizzazioni in corso di bronchite cronica.] 84
A60 antigen as a new tuberculin. 84
Coexistence of obesity and asthma determines a distinct respiratory metabolic phenotype 82
The effect of platelet-activating factor (PAF) on nasal airway resistance in healthy subjects is not mediated by nitric oxide. 82
Alveolar clearance dysfunction caused by air pollutants (study with DTPA-Tc99m). [Danno della clearance alveolareda aerocontaminanti (Studio con DTPA-Tc99m).] 82
Risposta immune IgG ed IgA verso l’antigene 60 nella tubercolosi extrapolmonare in una popolazione caucasica. 82
Evaluation of IgA-mediated humoral immune response against the mycobacterial antigen P-90 in diagnosis of pulmonary tuberculosis. 81
Produzione di ossido nitrico nell’ipertensione polmonare: implicazioni patogenetiche e terapeutiche. 81
Aspetti clinico-epidemiologici e radiologici della patologia respiratoria da AIDS (osservazioni in 53 casi). 80
Compendio di Medicina Interna 79
Cognitive disorders and cerebral perfusion in respiratory failure. [Disturbi cognitivi e perfusione cerebrale nella invalidità respiratoria.] 78
Effect of nifedipine and clenbuterol, alone and in association on gas exchange in COPD patients. 78
Separating smoking-related diseases using NMR-based metabolomics of exhaled breath condensate 76
Dose-response relation between in situ deposited or inhaled allergen and increase of mucosal permeability in patients with allergic bronchial asthma. 76
Detectability of endothelin on bronchoalveolar lavage fluid from normal subjects and patients with chronic pulmonary disease. 76
Changes of clinical parameters and reological properties of sputum during treatment with Nimesulide in patients suffering from chronic bronchitis (a controlled study versus placebo). [Modificazioni dei parametri clinici e delle proprietà reologiche dell'espettorato durante il trattamento con Nimesulide in pazienti affetti da bronchite cronica (studio controllato verso il placebo).] 75
Exhaled nitric oxide: Clinical applications in respiratory diseases 74
Ciliary movement and radioisotopic parameters of the mucociliary function in respiratory pathology [Battito ciliaree parametri radioisotopici di funzione muco-ciliare in patologia respiratoria.] 74
L’inibizione dell’NO previene l’incremento delle resistenze nasali indotto dalla BK ma non dal PAF. 74
Low alveolar and bronchial nitric oxide in severe uncomplicated obesity 73
Increase in exhaled nitric oxide in shoe and leather workers at the end of the work-shift 73
Weight loss and asthma control in severely obese asthmatic females. 73
Humming, nitric oxide, and paranasal sinus obstruction. 72
Lack of effect of nitric oxide inhibition on bronchial tone and methacholine induced bronchoconstriction. 72
La Latticodeidrogenasi sierica nell''AIDS: Marker di Polmonite da Pneumocystis carinii. 72
Pulmonary involvement in AIDS. a case report about pneumothorax and Pneumocystis carinii pneumonia (PPC). 72
Risposta umorale e cellulare all'antigene micobatterico A60 nella diagnosi di Tubercolosi. 71
Modificazioni del metabolismo di Endotelina-1 in pazienti con BPCO durante la fase di riacutizzazione e in risposta a carico proteico. 71
Corticoresistemza e corticodipendenza nell’asma bronchiale. 70
Sensitization to rodents (mouse/rat) in an urban atopic population without occupational exposure living in Naples, Italy. 70
Ipertensione polmonare 69
Association of Adams-Oliver syndrome with pulmonary arterio-venous malformation in the same family: a further support to the vascular hypothesis 68
Abnormalities of renal endothelin during acute exacerbation in chronic obstructive pulmonary disease. 68
Modificazioni dell'attività funzionale dell'epitelio alveolare in rapporto all'esposizione ad aerocontaminanti. 68
Respiratory infections in advanced lung cancer. 68
Regional cerebral blood flow of COPD patients is impaired. 68
Exhaled nitric oxide in severe obesity: effect of weight loss 67
La valutazione preoperatoria (nel paziente con neoplasia polmonare). 67
Severe pulmonary hypertension in chronic lung disease. long term effects on gas exchange of endothelin receptor antagonists or PDE5 inhibitors. 67
Inhibition of pulmonary nitric oxide production and airway hyperresponsiveness. 67
Monitoraggio terapeutico dell’asma bronchiale con ossido nitrico. 67
Maniscalco M, Sofia M, Weitzberg E, Carratu L, Lundberg JO. 66
Abnormalities of Endothelin-1 metabolism in pulmonary thromboembolism. 66
Produzione renale di ET-1 in corso di riacutizzazione della BPCO. 65
L' Ipertensione polmonare 65
Effect of bariatric surgery on the six-minute walk test in severe uncomplicated obesity 64
Familial outbreak of disseminated multi-drug resistant tuberculosis and meningitis. 64
Clinical, functional and biohumoral effects of single daily doses of a new sustained release theophylline in bronchial asthma patients. [Rilievi clinico-funzionali e bioumorali sugli effetti della somministrazione monoquotidiana di una nuova teofillina a rilascio controllato in pazienti broncoasmatici.] 64
Embolia polmonare e Broncopneumopatia cronica ostruttiva. 64
Diagnosi intrauterina di malformazione polmonare cistica. 64
Evaluation of humoral immune response against the mycobacterial antigen 60 in different clinical forms of pulmonary tuberculosis. 64
IgA immune response against the mycobacterial Antigen 60 in patients with active pulmonary tuberculosis. 63
Endothelin-1 excretion in urine in active Pulmonary Sarcoidosis and in other Interstitial Lung Disease 62
24-hours endothelin urinary excretion in patients with interstitial lung disease. 62
Long-term treatment with methotrexate in patients with corticosteroid-dependent bronchial asthma. 61
Ipertensione polmonare nelle malattie parenchimali del polmone 61
Evaluation of the efficacy and tolerance of rokitamycin in treating infections of the lower respiratory tract. 60
Intrarenal adaptation in COPD. [Adattamenti intrarenali nella BPCO.] 60
Effetti dell’inalazione di soluzioni ipotoniche e di L-NAME sui livelli di NO espirato in soggetti sani. 60
Role of Endothelin in acute and chronic pulmonary disease. 59
Effects of salmeterol on the bronchial reactivity to metacholine and bronchial clearance of 99mTc-DTPA [Effetti del salmeterolo sulla reattività bronchiale alla metacolina e sulla clearance bronchiale di DTPA-TC99m] 59
Nimesulide in the treatment of chronic bronchitis. 58
Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopy. 58
Morphofunctional aspects of the pulmonary endothelium and airway inflammation. [Aspetti morfo-funzionali dell'endotelio polmonare ed infiammazione delle vie aeree.] 58
Comportamento dei livelli di LDH sierica nella polmonite da P. carinii in pazienti AIDS. 58
Kidney pulmonary hypertension: another road on the map? 58
Endobronchial administration of iodine-131 B72.3 monoclonal antibody in patients with lung cancer. 57
Endobronchial deposition of radioactive monoclonal antibody in patients with inoperable non-small-cell carcinoma of the lung. 57
Evaluation of alveolar clearance by use of soluble radioaerosols. [Valutazione della clearance alveolare mediante radioaerosoli solubili.] 57
Scintigraphic indexes of the damage to the lung hematoperfusion in emphysema. Clinical interest and correlatingValues.[Indici scintigrafici di danno emato-perfusivo polmonare nell'Enfisema. Significato clinico e valore correlativo.] 57
Exhaled breath condensate: A new technique for monitoring exposure to toluene among healthy individuals. [Condensato dell'aria espirata: Nuova tecnica per il monitoraggio dell'esposizione a toluene in soggetti sani]. 57
Nasal nitric oxide measurements before and after repeated humming maneuvers 55
Exploring airway diseases by NMR-based metabonomics: a review of application to exhaled breath condensate 55
Totale 7.471
Categoria #
all - tutte 33.345
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.345


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202192 0 0 0 0 0 36 13 4 13 1 21 4
2021/2022505 3 0 0 4 1 18 11 21 56 64 65 262
2022/2023448 113 35 14 17 53 38 0 48 55 46 25 4
2023/2024574 14 76 90 26 85 35 7 25 4 13 119 80
2024/20253.563 258 281 8 74 118 169 361 176 342 344 1.150 282
2025/20263.631 735 513 642 596 989 156 0 0 0 0 0 0
Totale 9.533